Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?
Guilherme Rabinowits Department of Medical Oncology, Center for Head and Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, USA Abstract: Although cytotoxic chemotherapy has been used often in the management of Merkel cell carcinoma (MCC), its benefit remains uncertain. Despite being conside...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-09-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/is-this-the-end-of-cytotoxic-chemotherapy-in-merkel-cell-carcinoma-peer-reviewed-article-OTT |